CARDIOVASCULAR
hamburger

DESIGNED TO BE THE MOST DELIVERABLE TAVI VALVE

Aortic valve stenosis has been reported to be the most common valve abnormality.1 And when your patients present with aortic stenosis, the only definitive treatment is aortic heart valve replacement.2

Replacement can be achieved surgically or with transcatheter aortic valve implantation (TAVI).

Abbott’s dedication to offering optimal treatment—through the minimally invasive TAVI procedure—is apparent in the advantages that characterize its TAVI valve, Portico.

Chief among the advantages: Portico offers the lowest profile**, now with a sheathless indication.3,4

PORTICO VALVE

Portico is the first resheathable, self-expanding valve on the market*

REASONS TO CHOOSE PORTICO

When opting for the minimally invasive TAVI procedure, the key features of the Portico valve to consider include:

  • Designed to be the most deliverable TAVI valve
  • Can be fully repositioned, recaptured, and retrieved prior to full deployment5
  • Avoids the need for rapid pacing during deployment5,6
  • Provides hemodynamic stability—with no loss in hemodynamic pressure7
  • Offers earlier leaflet functionality with its intra-annular position5
  • Offers the lowest TAVI profile3,4**

Portico Valve

References

1. Faggiano P, et al. Epidemiology and cardiovascular risk factors in aortic stenosis. Cardiovasc Ultrasound. 2006;4:27. doi: 10.1186/1476-7120-4-27.
2. Ren X. Aortic stenosis. MedScape. https://emedicine.medscape.com/article/150638-overview. Published March 23, 2017.
3. Taramasso M, et al. Feasibility and safety of transfemoral sheathless Portico aortic valve implantation: preliminary results in a single center experience. Catheter Cardiovasc Interv. 2018;91(3):533-539. doi: 10.1002/ccd.27100.
4. Data on file at Abbott. Document 90237740.
5. Möllmann H, et al. Portico TF EU Pre-CE Mark 30-day outcomes for all 4 valve sizes. J Am Coll Cardiol Interv. 2017;10:1538–1547.
6. Portico IFU.
7. Bedogni F. Aortic valve replacement. JESFC2018.

* CE Mark for 23mm size obtained November 2012.
**Based on internal testing. Tests performed by and data on file at Abbott.

AP2946597-WBO Rev. A

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?